Literature DB >> 2022343

Theoretical studies on mechanism of MPTP action: ET interference by MPP+ (1-methyl-4-phenylpyridinium) with mitochondrial respiration vs. oxidative stress.

P Kovacic1, W D Edwards, G Ming.   

Abstract

This report demonstrates that ease of electron uptake by 1-methyl-4-phenylpyridinium (MPP+), apparently the active agent derived from MPTP, is influenced by conformation of the phenyl ring. From quantum mechanical calculations on MPP+, electron affinity is most negative for the nearly coplanar arrangement, indicating that the molecule is most readily reduced in this geometry. Ionization potential is largest in the perpendicular conformation, thus making for most facile oxidation in that form. Site binding would be expected to alter conformation in comparison with the situation in solution, and, hence, to influence reduction potential. We suggest that electron transfer by MPP+ may play a role in inhibition of mitochondrial respiration and in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022343     DOI: 10.3109/10715769109088938

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  3 in total

1.  Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

Authors:  S Samantaray; V H Knaryan; C Le Gal; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

Review 2.  Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders.

Authors:  Isidro Salcedo; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 3.  A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.

Authors:  Dong Seok Kim; Ho-Il Choi; Yun Wang; Yu Luo; Barry J Hoffer; Nigel H Greig
Journal:  Cell Transplant       Date:  2017-09       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.